首页 | 本学科首页   官方微博 | 高级检索  
检索        

孕中期异常甲胎蛋白与不良妊娠结局的相关性
引用本文:吴满武,俞信忠,杨志浩,张涛,罗婷婷.孕中期异常甲胎蛋白与不良妊娠结局的相关性[J].中国优生与遗传杂志,2012(11):82-83.
作者姓名:吴满武  俞信忠  杨志浩  张涛  罗婷婷
作者单位:浙江省绍兴市妇幼保健院,312000
摘    要:目的探讨孕中期甲胎蛋白(AFP)与不良妊娠结局的相关性,为妊娠管理提供建议。方法对孕中期14 008例孕妇进行唐氏筛查。研究组:①AFP MoM>2.0孕妇338例。②AFP MoM<0.5孕妇224例。依据AFP MoM值不同分组。对照组:AFP MoM值都在正常范围内的孕妇318例。回顾分析妊娠结局资料。结果①AFP MoM>2.0的孕妇发生出生缺陷(P<0.01)的机会明显比正常孕妇高。②AFP MoM>3.5的孕妇发生出生缺陷(P<0.001)和早产(P<0.05)的机会明显比正常孕妇高。③AFP MoM>5.0的孕妇发生出生缺陷(P<0.001)、早产(P<0.01)和胎儿窘迫(P<0.05)的机会明显比正常孕妇高。④AFP MoM<0.5和<0.25的孕妇均未发现与不良妊娠结局相关。结论异常水平的标志物除了能够提供开放性神经管缺损风险外,还能提供不良妊娠结局的风险信息,而这些信息对产前遗传咨询和妊娠管理是非常重要。

关 键 词:妊娠结局  甲胎蛋白(AFP)  中位数倍数(MoM)

The association between second -trimester maternal serum abnormal alpha- fetoprotein and adverse pregnancy out- come.
WU Man-wu,YU Xin-zhong,YANG Zhi-hao,ZHANG Tao,LUO Ting-ting.The association between second -trimester maternal serum abnormal alpha- fetoprotein and adverse pregnancy out- come.[J].Chinese Journal of Birth Health & Heredity,2012(11):82-83.
Authors:WU Man-wu  YU Xin-zhong  YANG Zhi-hao  ZHANG Tao  LUO Ting-ting
Institution:WU Man - wu, YU Xin - zhong, YANG Zhi - hao, ZHANG Tao, LUO Ting - ting ( Shaoxing Maternal and Child Health Care Hospital in Zhejiang Province, 312000 )
Abstract:Objective : Aim of this study is to determine the association between risk of adverse pregnancy outcome and abnormal maternal serum alpha - fetoprotein in second trimester screening. Abnormal levels of maternal serum markers provide information which is important for counseling and pregnancy management. Methods: A total of 14 008 pregnant women underwent maternal serum Down' s syndrome screening. Study groups include: (1) 338 cases were found to have a serum AFP of 〉 2. 0 multiples of the median (MoM). (2)cases serum were found to have a serum AFP 〈 0. 5 MoM. Pregnant women with abnormal AFP MoM were divided accord- ing to different levels of AFP MoM. 318 cases with normal levels of AFP MoM as control group. All pregnancy outcomes were analyzed retrospectively. Results : (1) Pregnant women with a serum AFP of 〉 2. 0 MoM have higher occurrence of birth defects ( P 〈 0. 01 ) than normal control study. (2) Pregnant women with a serum AFP of 〉 3.5 MoM have higher occurrence of birth defects ( P 〈 0. 001 ) and preterm labor ( P 〈 0. 05 ). (3)Pregnant women with a serum AFP of 〉 5.0 MoM have higher occurrence of birth defects ( P 〈 0. 001 ) and preterm labor ( P 〈 0.01 ) and fetal stress ( P 〈 0. 05 ). (4)Pregnant women with a serum AFP of 〈 0. 5 和 〈 0. 25 MoM were found to have no association with adverse outcomes. Conclusion: Abnormal levels of maternal serum markers can provide risk in- formation of adverse outcomes in addition to the risks for open neural tube defects. The information is important for counseling and pregnancy management.
Keywords:Pregnant outcome  Alpha- fetoproteiu (AFP)  Multiples of the median (MoM)
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号